JACC: Case Reports (Jul 2020)

Safety and Efficacy of Amiodarone in a Patient With COVID-19

  • Nadia Castaldo, MD,
  • Alberto Aimo, MD,
  • Vincenzo Castiglione, MD,
  • Cristiano Padalino, MD,
  • Michele Emdin, MD, PhD,
  • Carlo Tascini, MD, PhD

Journal volume & issue
Vol. 2, no. 9
pp. 1307 – 1310

Abstract

Read online

There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we report the first case of a patient affected by respiratory failure related to COVID-19 who recovered after only supportive measures and a short amiodarone course. (Level of Difficulty: Beginner.)

Keywords